AstraZeneca

News

Pressure relieved on AZ as details of Chinese probe emerge

AstraZeneca's exposure to liability in a Chinese investigation into illegal drug imports appears to be much less than had been feared.

News

Woman in protective clothing in a laboratory

Report says AZ's UK plant decision is not just about funding

It's been reported that the UK government made an offer of £78 million in funding for AstraZeneca's abandoned £450 million vaccine facility in Speke.

News

Boost to Enhertu's prospects as FDA clears Roche diagnostic

Roche gets the first FDA approval for a diagnostic test for HER2-ultralow breast cancer, now on the label of AstraZeneca and Daiichi Sankyo's Enhertu.

News

AstraZeneca abandons plan for £450m vaccine plant in UK

In a shock move, AstraZeneca has ditched its plan to invest £450m in a new vaccine manufacturing plant in the UK.

News

Enhertu gets first okay for HER2-ultralow breast cancer

Enhertu gets much-anticipated new FDA approval in breast cancer that expands its label and makes it an earlier option in the treatment pathway.

News

AstraZeneca reveals $570m investment in Canada

AstraZeneca has announced another major investment in Canada, tapping into the country's emergence as a "global hub" for clinical trials.

Pressure relieved on AZ as details of Chinese probe emerge

Report says AZ's UK plant decision is not just about funding

Boost to Enhertu's prospects as FDA clears Roche diagnostic

AstraZeneca abandons plan for £450m vaccine plant in UK

Enhertu gets first okay for HER2-ultralow breast cancer

AstraZeneca reveals $570m investment in Canada

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

AstraZeneca

Editor's Picks